• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

设计、合成及评价 6-(4-((取代-1H-1,2,3-三唑-4-基)甲基)哌嗪-1-基)菲啶类似物作为抗分枝杆菌剂。

Design, synthesis and evaluation of 6-(4-((substituted-1H-1,2,3-triazol-4-yl)methyl)piperazin-1-yl)phenanthridine analogues as antimycobacterial agents.

机构信息

Department of Chemistry, Birla Institute of Technology & Science-Pilani, Hyderabad Campus, R.R. District 500078, Andhra Pradesh, India.

出版信息

Bioorg Med Chem Lett. 2013 Dec 15;23(24):6805-10. doi: 10.1016/j.bmcl.2013.10.016. Epub 2013 Oct 14.

DOI:10.1016/j.bmcl.2013.10.016
PMID:24169232
Abstract

Focus in this Letter is made to design and synthesize a series of nineteen new 6-(4-((substituted-1H-1,2,3-triazol-4-yl)methyl)piperazin-1-yl)phenanthridine analogues employing click chemistry and evaluated for their anti-tubercular activity against Mycobacterium tuberculosis H37Rv. Among the tested compounds, 7f and 7 j exhibited good activity (MIC = 3.125 μg/mL), while 8a displayed excellent activity (MIC = 1.56 μg/mL) against the growth of M. tuberculosis H37Rv. In addition, 7f, 7 j and 8a compounds were subjected to cytotoxic studies against mouse macrophage (RAW264.7) cell lines and the selectivity index values are >15 indicating suitability of compounds for further drug development.

摘要

这封信的重点是设计和合成一系列十九个新的 6-(4-((取代-1H-1,2,3-三唑-4-基)甲基)哌嗪-1-基)菲啶类似物,采用点击化学方法,并评估它们对结核分枝杆菌 H37Rv 的抗结核活性。在所测试的化合物中,7f 和 7j 表现出良好的活性(MIC = 3.125 μg/mL),而 8a 对结核分枝杆菌 H37Rv 的生长表现出优异的活性(MIC = 1.56 μg/mL)。此外,化合物 7f、7j 和 8a 还进行了对小鼠巨噬细胞(RAW264.7)细胞系的细胞毒性研究,其选择性指数值>15,表明这些化合物适合进一步的药物开发。

相似文献

1
Design, synthesis and evaluation of 6-(4-((substituted-1H-1,2,3-triazol-4-yl)methyl)piperazin-1-yl)phenanthridine analogues as antimycobacterial agents.设计、合成及评价 6-(4-((取代-1H-1,2,3-三唑-4-基)甲基)哌嗪-1-基)菲啶类似物作为抗分枝杆菌剂。
Bioorg Med Chem Lett. 2013 Dec 15;23(24):6805-10. doi: 10.1016/j.bmcl.2013.10.016. Epub 2013 Oct 14.
2
Novel amide and sulphonamide derivatives of 6-(piperazin-1-yl)phenanthridine as potent Mycobacterium tuberculosis H37Rv inhibitors.6-(哌嗪-1-基)菲啶酰胺和磺酰胺衍生物作为新型结核分枝杆菌 H37Rv 抑制剂。
Eur J Med Chem. 2015 Mar 6;92:415-26. doi: 10.1016/j.ejmech.2015.01.013. Epub 2015 Jan 9.
3
Synthesis and evaluation of anti-tubercular activity of 6-(4-substitutedpiperazin-1-yl) phenanthridine analogues.6-(4-取代哌嗪-1-基)菲啶类似物的抗结核活性合成与评价
Eur J Med Chem. 2014 Mar 3;74:333-9. doi: 10.1016/j.ejmech.2014.01.005. Epub 2014 Jan 11.
4
Design, synthesis and antimycobacterial evaluation of 1-(4-(2-substitutedthiazol-4-yl)phenethyl)-4-(3-(4-substitutedpiperazin-1-yl)alkyl)piperazine hybrid analogues.设计、合成及 1-(4-(2-取代噻唑-4-基)苯乙基)-4-(3-(4-取代哌嗪-1-基)烷基)哌嗪杂合类似物的抗分枝杆菌活性评价。
Eur J Med Chem. 2014 Sep 12;84:605-13. doi: 10.1016/j.ejmech.2014.07.067. Epub 2014 Jul 21.
5
Design, synthesis and evaluation of 1,2,3-triazole-adamantylacetamide hybrids as potent inhibitors of Mycobacterium tuberculosis.设计、合成及评价 1,2,3-三唑-金刚烷乙酰胺杂合体作为潜在的结核分枝杆菌抑制剂。
Bioorg Med Chem Lett. 2014 Apr 15;24(8):1974-9. doi: 10.1016/j.bmcl.2014.02.061. Epub 2014 Mar 12.
6
Design, synthesis and antimycobacterial activity of various 3-(4-(substitutedsulfonyl)piperazin-1-yl)benzo[d]isoxazole derivatives.多种3-(4-(取代磺酰基)哌嗪-1-基)苯并[d]异恶唑衍生物的设计、合成及抗分枝杆菌活性
Eur J Med Chem. 2014 Nov 24;87:71-8. doi: 10.1016/j.ejmech.2014.09.043. Epub 2014 Sep 16.
7
Design and synthesis of 1H-1,2,3-triazoles derived from econazole as antitubercular agents.设计并合成了来源于益康唑的 1H-1,2,3-三唑类化合物,作为抗结核药物。
Bioorg Med Chem Lett. 2012 Nov 15;22(22):6844-7. doi: 10.1016/j.bmcl.2012.09.041. Epub 2012 Sep 23.
8
Rational design and synthesis of novel dibenzo[b,d]furan-1,2,3-triazole conjugates as potent inhibitors of Mycobacterium tuberculosis.新型二苯并[b,d]呋喃-1,2,3-三唑偶联物的合理设计与合成及其作为结核分枝杆菌有效抑制剂的研究
Eur J Med Chem. 2014 Jan;71:160-7. doi: 10.1016/j.ejmech.2013.10.082. Epub 2013 Nov 12.
9
Rational design, synthesis and antitubercular evaluation of novel 2-(trifluoromethyl)phenothiazine-[1,2,3]triazole hybrids.新型 2-(三氟甲基)吩噻嗪-[1,2,3]三唑杂合体的合理设计、合成与抗结核活性评价。
Bioorg Med Chem Lett. 2014 Jan 1;24(1):233-6. doi: 10.1016/j.bmcl.2013.11.031. Epub 2013 Nov 21.
10
Seeking potent anti-tubercular agents: Design, synthesis, anti-tubercular activity and docking study of various ((triazoles/indole)-piperazin-1-yl/1,4-diazepan-1-yl)benzo[d]isoxazole derivatives.寻找强效抗结核药物:各种((三唑/吲哚)-哌嗪-1-基/1,4-二氮杂环庚烷-1-基)苯并[d]异恶唑衍生物的设计、合成、抗结核活性及对接研究
Bioorg Med Chem Lett. 2016 May 1;26(9):2245-50. doi: 10.1016/j.bmcl.2016.03.059. Epub 2016 Mar 15.

引用本文的文献

1
Metal-free 2-isocyanobiaryl-based cyclization reactions: phenanthridine framework synthesis.无金属的 2-异氰基联苯基环化反应:菲啶骨架合成。
Mol Divers. 2024 Feb;28(1):419-435. doi: 10.1007/s11030-023-10743-2. Epub 2023 Oct 17.
2
Construction of Phenanthridinone Skeletons through Palladium-Catalyzed Annulation.通过钯催化环化反应构建菲啶酮骨架。
J Org Chem. 2023 Sep 1;88(17):12738-12743. doi: 10.1021/acs.joc.3c01429. Epub 2023 Aug 23.
3
Silver-Catalyzed Cascade Cyclization of Amino--1,2,3-Triazoles with 2-Alkynylbenzaldehydes: An Access to Pentacyclic Fused Triazoles.
银催化的氨基-1,2,3-三唑与 2-炔基苯甲醛的级联环化反应:一种获得五环稠合三唑的方法。
Molecules. 2022 Nov 4;27(21):7567. doi: 10.3390/molecules27217567.
4
Seeking potent anti-tubercular agents: design and synthesis of substituted--(6-(4-(pyrazine-2-carbonyl)piperazine/homopiperazine-1-yl)pyridin-3-yl)benzamide derivatives as anti-tubercular agents.寻找强效抗结核药物:取代的β-(6-(4-(吡嗪-2-羰基)哌嗪/高哌嗪-1-基)吡啶-3-基)苯甲酰胺衍生物作为抗结核药物的设计与合成
RSC Adv. 2020 Mar 25;10(21):12272-12288. doi: 10.1039/d0ra01348j. eCollection 2020 Mar 24.
5
Design of new bis-triazolyl structure for identification of inhibitory activity on COVID-19 main protease by molecular docking approach.通过分子对接方法设计新型双三唑基结构以鉴定其对新型冠状病毒主要蛋白酶的抑制活性
J Mol Struct. 2022 Feb 15;1250:131858. doi: 10.1016/j.molstruc.2021.131858. Epub 2021 Nov 3.